Air pollution and health: new early warning signs
Part of Blood & lymphatic, Cancer, Lungs & breathing clinical trials.
This study looks for new early warning signs (biomarkers) of how air pollution affects lung and blood health. It is for people with COPD, lung cancer, or leukemia who have never smoked much, as well as for healthy hospital workers.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 or older.
- You must have smoked fewer than 100 cigarettes (about 5 packs) in your entire life and not smoke now.
- You either have COPD, lung cancer, or leukemia, OR you are a healthy employee at one of the study hospitals.
- If you have lung cancer or leukemia, you cannot have had prior cancer treatment (chemotherapy or other drugs).
- You must be willing to sign a consent form to participate.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies blood and tissue samples from people with COPD, IPF, or lung cancer to find markers that can help diagnose and predict these conditions. It aims to discover why some lung diseases progress to cancer.
This study looks at different lung immune cell patterns and how they work in smokers who are not yet diagnosed with COPD or asthma. It may help researchers understand why some people are more likely to develop COPD, which could guide future prevention or early treatments.
This study compares the lungs of people with airway disease to healthy volunteers to understand inflammation and lung function. You may be eligible if you have airway disease or are a healthy adult.
This study uses breathing tests and other data from a lung health check program to see if a new algorithm can detect COPD or early signs of COPD. It could help identify lung problems sooner.
This study looks at how environmental pollutants affect people with suspected lung cancer. It may help understand what role pollution plays in lung disease.
This study examines how certain white blood cells behave in people with lung cancer or COPD. It aims to better understand the immune response, which could help develop new treatments.
Hear when a new COPD trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.